CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 5.82: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
52.82BINR554.73M · vs all stocks (USD)
Revenue (TTM)
6.05BINR63.58M · vs all stocks (USD)
Profit Margin
-29.57%52-Week Change
44.58%vs all stocks
Market Capitalization
52.82BINR554.73M · vs all stocks (USD)
Enterprise Value
56.37BINR592.08M · vs all stocks (USD)
Forward P/E
32.44xPrice to Sales (TTM)
8.73xPrice to Book (MRQ)
4.10xEnterprise to Revenue
6.95xEnterprise to EBITDA
73.88xGross Margin
36.30%Profit Margin
-29.57%Operating Margin
-12.26%Return on Assets (TTM)
1.08%Return on Equity (TTM)
1.60%Revenue (TTM)
6.05BINR63.58M · vs all stocks (USD)
Revenue per Share (TTM)
68.05INRUpdated Jul 20, 2026Quarterly Revenue Growth
-1.50%Gross Profit (TTM)
3.21BINR33.69M · vs all stocks (USD)
EBITDA (TTM)
763.02MINR8.01M · vs all stocks (USD)
Net Income (TTM)
-1.79BINR-18.80M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
3.55%Operating Cash Flow (TTM)
589.62MINR6.19M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
205.47MINR2.16M · vs all stocks (USD)
5-Year Average Dividend Yield
3.01%vs all stocks
Payout Ratio
0.00%Revenue
8.11BINRFY2026 · Mar 31, 2026Cost of Goods Sold
5.26BINRFY2026 · Mar 31, 2026Gross Profit
2.85BINRFY2026 · Mar 31, 2026Operating Income
1.59BINR16.65M · vs all stocks (USD)
Pre-tax Income
210.17MINRFY2026 · Mar 31, 2026Income Tax Expense
-1.92MINRFY2026 · Mar 31, 2026Net Income
205.47MINRFY2026 · Mar 31, 2026EBIT
342.75MINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
763.02MINRFY2026 · Mar 31, 2026Non-operating Interest Expense
132.59MINRFY2026 · Mar 31, 2026Net Income from Continuing Operations
203.55MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
589.62MINRFY2026 · Mar 31, 2026Free Cash Flow
-3.16BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
70.08MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
203.55MINRFY2026 · Mar 31, 2026Other Non-cash Items
48.56MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-140.94MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
478.44MINRFY2026 · Mar 31, 2026Capital Expenditures
-3.75BINRFY2026 · Mar 31, 2026Net Acquisitions
0.00INRFY2026 · Mar 31, 2026Net Investing Cash Flow
-3.75BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
-128.52MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-128.52MINRFY2026 · Mar 31, 2026Shares Outstanding
50.72MSharesUpdated Jul 20, 2026% Held by Insiders
69.84%vs all stocks
% Held by Institutions
20.12%vs all stocks
Total Cash (MRQ)
0.00INRvs all stocks (USD)
Total Debt (MRQ)
3.63BINR38.08M · vs all stocks (USD)
Current Ratio (MRQ)
2.45xBook Value per Share (MRQ)
253.98INRUpdated Jul 20, 2026Total Assets
19.11BINR200.70M · vs all stocks (USD)
Total Current Assets
6.84BINRFY2026 · Mar 31, 2026Total Liabilities
6.23BINRFY2026 · Mar 31, 2026Total Non-current Assets
12.27BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
3.44BINRFY2026 · Mar 31, 2026Total Current Liabilities
2.79BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
70.08MINRFY2026 · Mar 31, 2026Other Short-term Investments
770.66MINRFY2026 · Mar 31, 2026Accounts Receivable
2.64BINRFY2026 · Mar 31, 2026Inventory
2.56BINRFY2026 · Mar 31, 2026Accounts Payable
2.30BINRFY2026 · Mar 31, 2026Short-term Debt
301.36MINRFY2026 · Mar 31, 2026Other Current Liabilities
187.99MINRFY2026 · Mar 31, 2026Long-term Debt
3.32BINRFY2026 · Mar 31, 2026Common Stock (Book)
507.19MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
12.88BINR135.26M · vs all stocks (USD)
52-Week Low
480.00INRUpdated Jul 20, 202652-Week High
1.12KINRUpdated Jul 20, 202652-Week Change
44.58%vs all stocks
50-Day MA
885.30INRUpdated Jul 20, 2026200-Day MA
738.58INRUpdated Jul 20, 2026Avg 10-Day Volume
590.35KSharesUpdated Jul 20, 2026Avg 30-Day Volume
303.65KSharesUpdated Jul 20, 2026Diluted EPS (TTM)
4.06INRUpdated Jul 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.82: safe zoneNotable
Altman Z-Score: 5.82
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Altimmune, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Kingchem Liaoning Life Science Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Boryung Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Well Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Relmada Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
CHA Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Morepen Laboratories Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shandong Sinobioway Biomedicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule